Interacting Drugs |
Doxepin (systemic) vs Beta2-Agonists |
Security Level |
 |
Mechanism |
Beta2-Agonists: Tricyclic Antidepressants may enhance the adverse/toxic effect of Beta2-Agonists. |
Management |
Monitor therapy |
Doxepin (systemic) vs Beta2-Agonists
Post Review about Doxepin (systemic) vs Beta2-Agonists Click here to cancel reply.
Other Interactions of Doxepin (systemic)
Other Interactions of Beta2-Agonists
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.